Press & News
The next generation biopharmaceuticals
Press releases 2017
Older press releases
2017-11-17
2017-11-08
2017-09-06
Affibody in short
Affibody is a Swedish biotech company focused on developing next generation biopharmaceuticals based on its unique proprietary technology platforms: Affibody® molecules and Albumod™.
Upcoming reports Financial calendar
- Interim Report Q3 (Nov. 15, 2019)